The first properly controlled human clinical trial of turkesterone — a plant-derived ecdysteroid heavily marketed on social media as a natural muscle builder — has found no significant effect on muscle growth, strength, or body composition compared to placebo.

Study Design

The 12-week randomized, double-blind, placebo-controlled trial at the University of Texas enrolled 120 resistance-trained men aged 21-35.

Industry Reaction

Supplement companies generating an estimated $200 million in annual turkesterone sales have pushed back on the findings, citing animal studies and anecdotal evidence. Sports nutrition researchers note this pattern is common — compounds showing promise in rodent studies frequently fail to translate to human benefits at practical doses.